SYNEKTIK (SNT.WA) Financials
SNT.WA Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | 397.6 million | 228.7 million |
| 2023-09-30 | 299.9 million | 165.7 million |
| 2023-06-30 | 259.9 million | 142.0 million |
| 2023-03-31 | 240.3 million | 134.8 million |
SNT.WA Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | 113.4 million | ? |
| 2023-09-30 | 51.3 million | ? |
| 2023-06-30 | -5.5 million | ? |
| 2023-03-31 | 1.4 million | ? |
SNT.WA Net Income
| Date | Net Income |
|---|---|
| 2023-12-31 | 34.7 million |
| 2023-09-30 | 15.8 million |
| 2023-06-30 | 13.5 million |
| 2023-03-31 | 4.0 million |
SNT.WA Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | - | - | 14.3 million |
| 2023-09-30 | - | - | 17.4 million |
| 2023-06-30 | - | - | 16.6 million |
| 2023-03-31 | - | - | 10.9 million |
SNT.WA Shares Outstanding
SNT.WA Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | 8.6 million | 4.1 million | 10.7 million | - |
| 2023-09-30 | 2.0 million | 5.3 million | 9.6 million | - |
| 2023-06-30 | 290070 | 4.4 million | 11.6 million | - |
| 2023-03-31 | 290070 | 4.0 million | 8.0 million | - |
SNT.WA Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | 271.3 million | 206.6 million |
| 2023-09-30 | 135.7 million | 91.4 million |
| 2023-06-30 | 101.7 million | 68.7 million |
| 2023-03-31 | 65.7 million | 47.4 million |
SNT.WA
Price: PLN129.40
Dividend Yield: 0.02%
Forward Dividend Yield: 2.38%
Payout Ratio: 38.02%
Dividend Per Share: 3.03 PLN
Earnings Per Share: 7.98 PLN
P/E Ratio: 15.48
Exchange: WSE
Sector: Healthcare
Industry: Medical Devices
Market Capitalization: 1.1 billion
Average Dividend Frequency: 1
Years Paying Dividends: 5
DGR3: 16.67%